A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing ...

The researchers described the unprecedented speed of the oversight steps as being "through alternative procedures." In month ...

In a record-breaking six months, scientists developed a custom Crispr therapy for KJ Muldoon, an infant with a fatal genetic ...

Aldevron, a global leader in the production of DNA, RNA and protein, together with Integrated DNA Technologies (IDT), a global leader in genomics solutions, announced the successful manufacture of the ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...

Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a ...

The global CRISPR Market, valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching US$3.21 billion in 2025 and an impressive US$5.47 billion by 2030. The growing ...

One of the most commonly used gene-delivery methods relies on engineered viruses to insert stretches of genetic material into ...

CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that new data from a study in non-human primates (NHPs) has ...

Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a ...

Eligo Bioscience has secured a $5m grant from the French Government to expedite the development of its topical gene delivery ...